Search

Insulet Corp

Geschlossen

BrancheGesundheitswesen

145.84 3.51

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

138.15

Max

143.3

Schlüsselkennzahlen

By Trading Economics

Einkommen

3.9M

95M

Verkäufe

40M

802M

KGV

Branchendurchschnitt

26.751

57.002

EPS

1.66

Gewinnspanne

11.85

Angestellte

5,400

EBITDA

-22M

132M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+21.7% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.8B

9.9B

Vorheriger Eröffnungskurs

142.33

Vorheriger Schlusskurs

145.84

Nachrichtenstimmung

By Acuity

75%

25%

310 / 340 Ranking in Healthcare

Insulet Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. Aug. 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14. Aug. 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13. Aug. 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

12. Aug. 2026, 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

11. Aug. 2026, 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

10. Aug. 2026, 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

7. Aug. 2026, 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6. Aug. 2026, 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5. Aug. 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4. Aug. 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3. Aug. 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31. Juli 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29. Juli 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28. Juli 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27. Juli 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24. Juli 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22. Juli 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20. Juli 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Peer-Vergleich

Kursveränderung

Insulet Corp Prognose

Kursziel

By TipRanks

21.7% Vorteil

12-Monats-Prognose

Durchschnitt 174.45 USD  21.7%

Hoch 216 USD

Tief 144 USD

Basierend auf 23 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Insulet Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

23 ratings

13

Buy

9

Halten

1

Sell

Stimmung

By Acuity

310 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat